Board of Unichem Laboratories to consider proposal for consolidation of generic formulations biz in US | Capital Market News

On September 30, 2024

The Board of Unichem Laboratories will meet on September 30, 2024 to consider and approve integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company’s holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company’s wholly owned subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content